(Q44557583)

4 December 2017

title

Reduction of cirrhosis and hepatocellular carcinoma with antiviral therapy in chronic hepatitis B. (English)

1 reference

4 December 2017

0 references

hepatocellular carcinoma

1 reference

1

0 references

language of work or name

English

0 references

publication date

19 September 2013

1 reference

4 December 2017

1 reference

4 December 2017

volume

58

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

1856

1 reference

Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy

4 December 2017

cites work

1 reference

Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma.

21 January 2018

1 reference

Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis.

21 January 2018

1 reference

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma

21 January 2018

1 reference

Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications

21 January 2018

1 reference

Lamivudine for patients with chronic hepatitis B and advanced liver disease

21 January 2018

1 reference

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/HEP.26358

1 reference

4 December 2017

1 reference